# A Scandinavian Non-interventional Study of Adherence to RebiSmart Administered Rebif New Formulation (RNF) Treatment in Relapsing Remitting Multiple Sclerosis (RRMS) Subjects

> **NCT01125475** · — · COMPLETED · sponsor: **Merck KGaA, Darmstadt, Germany** · enrollment: 61 (actual)

## Conditions studied

- Relapsing Remitting Multiple Sclerosis (RRMS)

## Interventions

- **DEVICE:** RebiSmart

## Key facts

- **NCT ID:** NCT01125475
- **Lead sponsor:** Merck KGaA, Darmstadt, Germany
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2012-03
- **Final completion:** —
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2014-07-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01125475

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01125475, "A Scandinavian Non-interventional Study of Adherence to RebiSmart Administered Rebif New Formulation (RNF) Treatment in Relapsing Remitting Multiple Sclerosis (RRMS) Subjects". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01125475. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*